Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) Net Preferred Shares Issued and Repurchased (2019 - 2026)

Updated

Korro Bio (KRRO) posted Net Preferred Shares Issued and Repurchased of $45.46 million for FY2023.

Analysis

Korro Bio (KRRO) Net Preferred Shares Issued and Repurchased (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Korro Bio 281.05 Mn -128.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21,000.00
Mar 31, 2026 5.04 Mn
Jun 30, 2023 -42,000.00
Mar 31, 2023 45.50 Mn
Sep 30, 2019 61.69 Mn
Mar 31, 2019 266,000.00
API Access

Korro Bio Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=KRRO&period=max&api_key=YOUR_API_KEY